Publication | Closed Access

Safety and efficacy of an anti-claudin-5 monoclonal antibody to increase blood–brain barrier permeability for drug delivery to the brain in a non-human primate

Blood–brain BarrierBlood–brain Barrier PermeabilityMedicinePharmacologyExperimental TherapeuticDrug Delivery SystemsNeuropharmacologyPharmacotherapyNeurologyNeuroprotectionCerebral Blood FlowNeuroimmunologyAnti-claudin-5 Monoclonal AntibodyCerebral Vascular Regulation